Jefferies Downgrades Supernus Pharmaceuticals to Hold

Jefferies downgrades Supernus Pharmaceuticals (NASDAQ:SUPN) from Buy to Hold.

Benzinga · 11/06/2019 11:35

Jefferies downgrades Supernus Pharmaceuticals (NASDAQ:SUPN) from Buy to Hold.